Arena’s CEO Leaves Mast’s Board as Both Companies’ Experimental PAH Therapies Continue To Advance
The progress of two promising experimental PAH therapies has led one of the two drug development companies working on them to part ways with a board member in order to avoid a conflict of interest. Mast Therapeutics, Inc. recently announced the resignation of Jack Lief from its board of directors.